Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status

LSKL, Inhibitor of Thrombospondin (TSP-1)

Catalog Number Pack Size List Price* Promo Price* Quantity
HY-P0299-5MG 5 mg 130,00 110,50 Add
HY-P0299-10MMO 10 mM * 1 mL 143,00 121,60 Add
HY-P0299-10MG 10 mg 187,00 159,00 Add
HY-P0299-25MG 25 mg 373,00 317,10 Add

* CHF, excl. 7.7% VAT and shipping costs

Product Description

LSKL, Inhibitor of Thrombospondin (TSP-1) is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) can readily crosse the blood-brain barrier.

Category Peptide
Supplier MedChem Express
Application Cancer-Kinase/protease
Regulatory Status RUO
Format Solubility: DMSO : ≥ 100 mg/mL (218.05 mM) ; H2O : 50 mg/mL (109.03 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Molecular Formula C21H42N6O5
Molecular Weight 458.6
CAS-Number [283609-79-0]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support

Business Development

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern


If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.

© Copyright 2021 Lucerna-Chem AG, Switzerland